Weil Supercharges IP Litigation Practice with Star Trial Team Led by New Co-Heads

The new hires bring decades of combined experience representing some of the world’s most influential companies in high-profile patent, trade secret, and technology-related litigation. Known for their trial prowess and deep understanding of the ever-evolving IP landscape, the trio has earned accolades from clients and industry publications alike.

Doug Lumish is widely regarded as one of the top patent litigators in the U.S., with a strong track record of success in jury trials and Federal Circuit appeals. Jeff Homrig brings deep experience in cross-border IP disputes, with a focus on electronics and life sciences. Gabe Gross is praised for his work in IP-heavy jury trials, particularly in Northern California and Texas courts.

The team will operate across Weil’s Bay Area and Texas offices, reflecting the firm’s strategic emphasis on innovation hubs where IP disputes are most active. Their arrival is expected to position Weil as a go-to firm for Fortune 500 companies seeking sophisticated representation in technology and life sciences litigation.

Jonathan Polkes and David Lender, Co-Chairs of Weil’s global Litigation Department, described the addition as “transformational,” emphasizing that the move further aligns with Weil’s commitment to being at the forefront of IP litigation.

“This team’s arrival elevates our ability to deliver trial-ready IP counsel with unparalleled depth and experience,” said Polkes. “Doug, Jeff, and Gabe are not only exceptional litigators but also strategic advisors who understand what’s at stake for innovative companies facing complex IP challenges.”

The expansion comes as IP disputes grow increasingly central to business strategy, particularly in emerging technologies like AI, semiconductors, biotech, and telecommunications. The newly formed IP, Technology & Science Litigation Practice will work closely with Weil’s transactional IP, patent prosecution, and antitrust teams to